Clinical efficacy and tolerability of a topical formulation containing fluralaner, moxidectin, and praziquantel¹ applied every three months against fleas in naturally infested dogs.
Clinical efficacy and tolerability of a quarterly topical formulation containing fluralaner, moxidectin, and praziquantel¹ against ticks in naturally infested dogs.
Efectividad, tolerancia y residualidad de una tableta blanda a base de soralaner, moxidectina, pirantel y R-praziquantel para el tratamiento y control de pulgas en caninos naturalmente infestados"
Evaluation of the Onset of Flea-Killing Activity of a Monthly Oral Formulation Containing Sarolaner, Moxidectin, Pyrantel, and R-Praziquantel in Naturally Infested Dogs
Effectiveness, tolerability, and residual effect of a sarolaner-based chewable tablet for the treatment and control of ticks in naturally infested canines
Effectiveness, tolerability, and residual effect of a sarolaner-based chewable tablet for the treatment and control of fleas in naturally infested canines
Safety assessment of a monthly sarolaner-based chewable tablet in canines
Evaluation of the onset time of flea-killing activity of a monthly oral formulation based on sarolaner in canines